Literature DB >> 8835507

HLA-B27 and HLA-B73 polymorphism and its role on antigenicity, peptide presentation, and disease susceptibility.

J A Lopez De Castro1.   

Abstract

Current ideas on the structure, evolution, and disease association of HLA-B27 antigens are presented, with emphasis on the effect of HLA-B27 polymorphism on T-cell recognition and antigen-presenting properties of these molecules. The molecular relationship between HLA-B27 and HLA-B73, and its implications for a putative pathogenetic role of the later antigen are discussed.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8835507     DOI： 10.1007/bf03342650

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  24 in total

1.  The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC.

Authors:  D R Madden; J C Gorga; J L Strominger; D C Wiley
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

2.  Identification of self peptides bound to purified HLA-B27.

Authors:  T S Jardetzky; W S Lane; R A Robinson; D R Madden; D C Wiley
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

Review 3.  Guilt by association: HLA-B27 and ankylosing spondylitis.

Authors:  R Benjamin; P Parham
Journal:  Immunol Today       Date:  1990-04

Review 4.  HLA-B27 and HLA-A2 subtypes: structure, evolution and function.

Authors:  J A López de Castro
Journal:  Immunol Today       Date:  1989-07

5.  Differences in peptide-binding specificity of two ankylosing spondylitis-associated HLA-B27 subtypes.

Authors:  D Fruci; R H Butler; G Greco; P Rovero; L Pazmany; E Vigneti; R Tosi; N Tanigaki
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

6.  HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations.

Authors:  C López-Larrea; K Sujirachato; N K Mehra; P Chiewsilp; D Isarangkura; U Kanga; O Dominguez; E Coto; M Penã; F Setién
Journal:  Tissue Antigens       Date:  1995-03

7.  Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs.

Authors:  O Rötzschke; K Falk; S Stevanović; V Gnau; G Jung; H G Rammensee
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

Review 8.  Structure, function, and disease association of HLA-B27.

Authors:  J A López de Castro
Journal:  Curr Opin Rheumatol       Date:  1994-07       Impact factor: 5.006

9.  HLA-B73: an atypical HLA-B molecule carrying a Bw6-epitope motif variant and a B pocket identical to HLA-B27.

Authors:  C Vilches; R de Pablo; M J Herrero; M E Moreno; M Kreisler
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

10.  NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80.

Authors:  M Cella; A Longo; G B Ferrara; J L Strominger; M Colonna
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307
View more
  2 in total

1.  Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies.

Authors:  F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

2.  Alteration of HLA-B27 peptide presentation after infection of transfected murine L cells by Shigella flexneri.

Authors:  F Boisgérault; J Mounier; V Tieng; M C Stolzenberg; I Khalil-Daher; M Schmid; P Sansonetti; D Charron; A Toubert
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.